Calder Biosciences, Inc. is a molecular engineering company based in Brooklyn, NY, specializing in the development of innovative vaccines using their proprietary 3D-Vaxlock technology. Their vaccines aim to provide safe, effective, and durable protection against a range of viral infections, including RSV, influenza, and other harmful pathogens.
With a focus on global health issues caused by viral infections, Calder Biosciences utilizes state-of-the-art technology and scientific expertise to engineer site-specific, covalent crosslinks in proteins, creating subunit vaccine immunogens that elicit highly protective immune responses. Their commitment to industry leadership, research partnerships, and rigorous safety and efficacy testing positions them as a leading player in the field of vaccine development.
Generated from the website